You can buy or sell OTLK and other stocks, options, ETFs, and crypto commission-free!
Outlook Therapeutics, Inc. Common Stock, also called Outlook Therapeutics, is a clinical-stage biopharmaceutical company. Read More The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.
Cranbury, New Jersey
52 Week High
52 Week Low
-$0.58 per share